NYSE:STESteris Stock Price, Forecast & News

Steris' stock was trading at $145.25 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, STE shares have increased by 6.2% and is now trading at $154.22.
View which stocks have been most impacted by Coronavirus.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Steris in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Steris.

Steris is scheduled to release its next quarterly earnings announcement on Monday, November 2nd 2020.
View our earnings forecast for Steris.

Steris PLC (NYSE:STE) issued its earnings results on Monday, August, 3rd. The medical equipment provider reported $1.31 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.98 by $0.33. The medical equipment provider earned $668.90 million during the quarter, compared to the consensus estimate of $643.38 million. Steris had a net margin of 13.69% and a return on equity of 16.24%. Steris's revenue was down 4.0% on a year-over-year basis. During the same period last year, the business earned $1.23 earnings per share.
View Steris' earnings history.

Steris announced a quarterly dividend on Monday, August 3rd. Shareholders of record on Thursday, August 27th will be given a dividend of $0.40 per share on Thursday, September 24th. This represents a $1.60 annualized dividend and a dividend yield of 1.04%. The ex-dividend date of this dividend is Wednesday, August 26th. This is an increase from Steris's previous quarterly dividend of $0.37.
View Steris' dividend history.

3 brokerages have issued 12-month price targets for Steris' stock. Their forecasts range from $170.00 to $170.00. On average, they anticipate Steris' share price to reach $170.00 in the next year. This suggests a possible upside of 10.2% from the stock's current price.
View analysts' price targets for Steris.

News articles about STE stock have trended very negative recently, according to InfoTrie Sentiment. The research group ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Steris earned a news impact score of -3.4 on InfoTrie's scale. They also gave headlines about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future.
View the latest news about Steris.

Steris saw a decline in short interest during the month of July. As of July 31st, there was short interest totaling 855,500 shares, a decline of 6.2% from the July 15th total of 911,800 shares. Based on an average daily trading volume, of 564,000 shares, the short-interest ratio is presently 1.5 days. Currently, 1.0% of the shares of the company are sold short.
View Steris' Short Interest.

Some companies that are related to Steris include Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Stryker (SYK), Becton Dickinson and (BDX), Boston Scientific (BSX), Edwards Lifesciences (EW), DexCom (DXCM), Baxter International (BAX), IDEXX Laboratories (IDXX), ResMed (RMD), Hologic (HOLX), Teleflex (TFX), Varian Medical Systems (VAR) and ABIOMED (ABMD).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Steris investors own include Johnson & Johnson (JNJ), Pfizer (PFE), AbbVie (ABBV), Home Depot (HD), Mastercard (MA), AT&T (T), Abbott Laboratories (ABT), Cisco Systems (CSCO), Gilead Sciences (GILD) and Mcdonald's (MCD).

Steris trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

Steris' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Bessemer Group Inc. (1.09%), Principal Financial Group Inc. (0.91%), Fisher Asset Management LLC (0.79%), Congress Asset Management Co. MA (0.74%), Villere ST Denis J & Co. LLC (0.72%) and Alta Capital Management LLC (0.59%). Company insiders that own Steris stock include Cary L Majors, Cynthia L Feldmann, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Renato Tamaro, Richard Martin Steeves, Walter M Rosebrough Jr and Walter M Rosebrough, Jr.
View institutional ownership trends for Steris.

STE stock was sold by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC, Assenagon Asset Management S.A., Robeco Institutional Asset Management B.V., Frontier Capital Management Co. LLC, GW&K Investment Management LLC, New York State Common Retirement Fund, Arizona State Retirement System, and WINTON GROUP Ltd. Company insiders that have sold Steris company stock in the last year include John Adam Zangerle, Mohsen Sohi, Renato Tamaro, and Richard Martin Steeves.
View insider buying and selling activity for Steris.

STE stock was purchased by a variety of institutional investors in the last quarter, including TimesSquare Capital Management LLC, Retirement Systems of Alabama, Principal Financial Group Inc., Bessemer Group Inc., Alta Capital Management LLC, McCollum Christoferson Group LLC, Princeton Portfolio Strategies Group LLC, and Envestnet Asset Management Inc..
View insider buying and selling activity for Steris.

Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of STE stock can currently be purchased for approximately $154.22.

Steris has a market capitalization of $13.10 billion and generates $3.03 billion in revenue each year. The medical equipment provider earns $407.61 million in net income (profit) each year or $5.64 on an earnings per share basis. Steris employs 13,000 workers across the globe.

The official website for Steris is www.steris.com.

Steris' mailing address is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. The medical equipment provider can be reached via phone at 353-1232-2000 or via email at [email protected]